We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Antibiotics Aim to Block Quorum Sensing

By Biotechdaily staff writers
Posted on 12 Jul 2006
Researchers have shown that an alpha-adrenergic antagonist could block the quorum sensing receptor (QseC receptor) of Escherichia coli O157:H7, which prevents the pathogenic bacteria from colonizing and infecting the intestinal tract.

Quorum sensing is a cell-to-cell signaling mechanism in which bacteria secrete hormone-like compounds called autoinducers. More...
When these auto-inducers reach a certain threshold concentration, they interact with bacterial transcriptional regulators, thereby regulating gene expression.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) had previously shown that the AI-3 quorum-sensing system is the mechanism by which E coli O157:H7 interacts with the eukaryotic hormones epinephrine/norepinephrine. This interaction activates the transcription of virulence genes in the bacteria.

In the current study, the investigators worked with a rabbit model to evaluate the ability of alpha and beta-adrenergic antagonists to interfere with the bacterial quorum sensing system. They reported in the June 27, 2006, online edition of the Proceedings of the [U.S.] National Academy of Sciences that the competitive nonselective alpha-adrenergic receptor antagonist. phentolamine bound to the E coli QseC receptor and prevented it from sensing the environmental signals that normally would have caused it to express its virulence genes.

"This receptor is found in many pathogens, so we can use this knowledge to design specific antagonists to block bacterial infections,” said senior author Dr. Vanessa Sperandio, assistant professor of microbiology at the University of Texas Southwestern Medical Center. "Overuse of antibiotics has led bacteria to develop resistance to antibiotics, so a novel type of therapy is needed.”



Related Links:
University of Texas Southwestern Medical Center

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.